These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 19172456)

  • 1. Endothelial dysfunction in patients with noncomplicated and complicated hypertension.
    Goch A; Banach M; Mikhailidis DP; Rysz J; Goch JH
    Clin Exp Hypertens; 2009 Feb; 31(1):20-30. PubMed ID: 19172456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelium and angiogenesis in white coat hypertension.
    Karter Y; Aydin S; Curgunlu A; Uzun H; Ertürk N; Vehid S; Kutlu A; Simsek G; Yücel R; Arat A; Ozturk E; Erdine S
    J Hum Hypertens; 2004 Nov; 18(11):809-14. PubMed ID: 15215878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial dysfunction in patients with kidney failure and vascular risk factors: acute effects of hemodialysis.
    Migliacci R; Falcinelli F; Imperiali P; Floridi A; Nenci GG; Gresele P
    Ital Heart J; 2004 May; 5(5):371-7. PubMed ID: 15185901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin-1 plasma concentration in children and adolescents with atherogenic risk factors.
    Głowińska B; Urban M; Hryniewicz A; Peczyńska J; Florys B; Al-Hwish M
    Kardiol Pol; 2004 Oct; 61(10):329-38. PubMed ID: 15841114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for enhanced 8-isoprostane plasma levels, as index of oxidative stress in vivo, in patients with coronary artery disease.
    Vassalle C; Botto N; Andreassi MG; Berti S; Biagini A
    Coron Artery Dis; 2003 May; 14(3):213-8. PubMed ID: 12702924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial dysfunction in patients with coronary atherosclerosis.
    Chapidze L; Kapanadze S; Dolidze N; Bakhutashvili Z; Latsabidze N
    Georgian Med News; 2007 Jan; (142):20-2. PubMed ID: 17327627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide: link between endothelial dysfunction and inflammation in patients with peripheral arterial disease of the lower limbs.
    de Haro Miralles J; Martínez-Aguilar E; Florez A; Varela C; Bleda S; Acin F
    Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):107-12. PubMed ID: 19376804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum nitric oxide metabolite (NO(x)) levels in hypertensive patients at rest: a comparison of age, gender, blood pressure and complications using normotensive controls.
    Higashino H; Miya H; Mukai H; Miya Y
    Clin Exp Pharmacol Physiol; 2007 Aug; 34(8):725-31. PubMed ID: 17600548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of endothelial cell dysfunction in essential hypertension.
    Sainani GS; Maru VG
    J Assoc Physicians India; 2004 Dec; 52():966-9. PubMed ID: 15884454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intensive lifestyle changes on endothelial function and on inflammatory markers of atherosclerosis.
    Dod HS; Bhardwaj R; Sajja V; Weidner G; Hobbs GR; Konat GW; Manivannan S; Gharib W; Warden BE; Nanda NC; Beto RJ; Ornish D; Jain AC
    Am J Cardiol; 2010 Feb; 105(3):362-7. PubMed ID: 20102949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imbalance between the endothelial cell-derived contracting factors prostacyclin and angiotensin II and nitric oxide/cyclic GMP in human primary varicosis.
    Schuller-Petrovic S; Siedler S; Kern T; Meinhart J; Schmidt K; Brunner F
    Br J Pharmacol; 1997 Oct; 122(4):772-8. PubMed ID: 9375976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma endothelin-1 levels in patients with peripheral arterial occlusive disease at different Fontaine's stages.
    Mangiafico RA; Malatino LS; Santonocito M; Sarnataro F; Dell'Arte S; Messina R; Santangelo B
    Panminerva Med; 1999 Mar; 41(1):22-6. PubMed ID: 10230252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A study of the relationship between remodeling of left ventricle and endothelial injury and pro-inflammatory mediators in different stages of essential hypertension].
    Cai JY; Zhai GL; Gao W; Zhu L; Li Y
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Dec; 20(12):743-5. PubMed ID: 19111125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolites of the L-arginine-NO pathway in patients with left-to-right shunt.
    Gorenflo M; Zheng C; Pöge A; Bettendorf M; Werle E; Fiehn W; Ulmer HE
    Clin Lab; 2001; 47(9-10):441-7. PubMed ID: 11596905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased plasma endothelin level as an endothelial marker of cardiovascular risk in patients with active acromegaly: a comparison with plasma homocysteine.
    Kirilov G; Zacharieva S; Alexandrov AS; Lozanov V; Mitev V
    Methods Find Exp Clin Pharmacol; 2009 Sep; 31(7):457-61. PubMed ID: 19907721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreasing plasma endothelin-1 and unchanged plasma neopterin during folate supplementation in hyperhomocysteinemia.
    Gottsäter A; Forsblad J; Mattiasson I; Lindgärde F
    Int Angiol; 2002 Jun; 21(2):158-64. PubMed ID: 12110777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of salt intake on endothelium-derived factors in a group of patients with essential hypertension.
    Bragulat E; de la Sierra A; Antonio MT; Jiménez W; Urbano-Márquez A ; Coca A
    Clin Sci (Lond); 2001 Jul; 101(1):73-8. PubMed ID: 11410117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor and nitric oxide serum levels in arterial hypertension.
    Vyzantiadis T; Karagiannis A; Douma S; Harsoulis P; Vyzantiadis A; Zamboulis C
    Clin Exp Hypertens; 2006 Oct; 28(7):603-9. PubMed ID: 17032626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma nitroso compounds are decreased in patients with endothelial dysfunction.
    Heiss C; Lauer T; Dejam A; Kleinbongard P; Hamada S; Rassaf T; Matern S; Feelisch M; Kelm M
    J Am Coll Cardiol; 2006 Feb; 47(3):573-9. PubMed ID: 16458138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of assessing coronary flow velocity reserve and plasma endothelin-1 in hypertensive patients.
    Fujii H; Takiuchi S; Kamide K; Horio T; Niizuma S; Tanaka N; Hashimoto S; Nakatani S; Fukagawa M; Kawano Y
    Hypertens Res; 2005 Nov; 28(11):911-6. PubMed ID: 16555580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.